Cation-exchange high-performance liquid chromatography assay for the nigrostriatal toxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B generated metabolites in brain tissues.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Chromatography A

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0021-9673(01)96513-6PMID 3498735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quantification of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion in brain tissue by gas chromatography/mass spectrometry.

  1986cited by this paper
• Interactions of the 1-methyl-4-phenyl-2,3-dihydropyridinium species with synthetic dopamine-melanin.

  1986cited by this paper
• Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.

  1985cited by this paper
• Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

  1985cited by this paper
• Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1985cited by this paper
• Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.

  1985cited by this paper
• HPLC-assay with electrochemical detection for the neurotoxin MPTP, its metabolite MPP+ and MPTP-analogues in biological samples after purification over Sephadex G10.

  1985cited by this paper
• Metabolism of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by liver homogenate fractions.

  1985cited by this paper
• 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.

  1984cited by this paper
• Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism

  1984cited by this paper
• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

  1984cited by this paper
• Pargyline prevents MPTP-induced parkinsonism in primates.

  1984cited by this paper
• Chronic parkinsonism secondary to intranasal administration of a product of meperidine-analogue synthesis.

  1984cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I

  1966cited by this paper

• Novel Approaches to PET Imaging Neuroinflammation

  2019cites this paper
• Disruption of lateral olivocochlear neurons with a dopaminergic neurotoxin depresses spontaneous auditory nerve activity.

  2014cites this paper
• Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents

  2012cites this paper
• Susceptibility to a parkinsonian toxin varies during primate development.

  2012cites this paper
• Protocol for the MPTP mouse model of Parkinson's disease

  2007cites this paper
• Disruption of Lateral Olivocochlear Neurons via a Dopaminergic Neurotoxin Depresses Sound-Evoked Auditory Nerve Activity

  2005cites this paper
• Diversity in Mechanisms of Substrate Oxidation by Cytochrome P450 2D6

  2001cites this paper
• DEVELOPMENT OF AN HPLC METHOD FOR THE ANALYSIS OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE IN A POTENTIAL ANTIPSYCHOTICACTIVE PHARMACEUTICAL INGREDIENT

  2000cites this paper
• Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization.

  1997cites this paper
• 2‐Deoxyglucose Enhances 1‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine‐Induced ATP Loss in the Mouse Brain

  1993cites this paper
• Toxicity of the 1-methyl-4-phenyl-2,3-dihydropyridinium and 1-methyl-4-phenylpyridinium species in primary cultures of mouse astrocytes.

  1992cites this paper
• 1‐Methyl‐4‐(2′‐Ethylphenyl)‐1,2,3,6‐Tetrahydropyridine‐ Induced Toxicity in PC12 Cells Is Enhanced by Preventing Glycolysis

  1992cites this paper
• Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity

  1992cites this paper
• Production and disposition of 1‐methyl‐4‐phenylpyridinium in primary cultures of mouse astrocytes

  1992cites this paper
• Role of Astrocytes in MPTP Metabolism and Toxicity a

  1992cites this paper
• Toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in primary cultures of mouse astrocytes.

  1992cites this paper
• Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite.

  1991cites this paper
• MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

  1991cites this paper
• Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice.

  1991cites this paper
• The Importance of MPP + Localization for the Manifestation of MPTP-Induced Neurotoxicity

  1991cites this paper
• 4'-alkylated analogs of 1-methyl-4-phenylpyridinium ion are potent inhibitors of mitochondrial respiration.

  1990cites this paper
• 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine‐ and 1‐Methyl‐4‐(2′‐Ethylphenyl)‐1,2,3,6‐Tetrahydropyridine‐Induced Toxicity in PC 12 Cells: Role of Monoamine Oxidase A

  1990cites this paper
• Biochemistry and genetics of monoamine oxidase.

  1990cites this paper
• Studies on the cytochrome P-450 catalyzed ring alpha-carbon oxidation of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

  1990cites this paper
• Depletion of cardiac norepinephrine but not brain catecholamines by MPTP-N-oxide in mice.

  1990cites this paper
• Effects of N-methylmercaptoimidazole on the disposition of MPTP and its metabolites in mice.

  1990cites this paper
• Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B.

  1989cites this paper
• A sheep model for MPTP induced Parkinson-like symptoms.

  1989cites this paper
• Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by bovine brain microvessel endothelial cells.

  1989cites this paper
• Oxidation of Analogs of l‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine by Monoamine Oxidases A and B and the Inhibition of Monoamine Oxidases by the Oxidation Products

  1989cites this paper
• Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

  1989cites this paper
• Chemical oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its in vivo metabolism in rat brain and liver.

  1988cites this paper
• Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1988cites this paper
• Metabolic studies on the nigrostriatal toxin MPTP and its MAO B generated dihydropyridinium metabolite MPDP+.

  1988cites this paper
• Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.

  1988cites this paper